James Isaacs, MD
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center · The Cleveland Clinic · Cleveland Clinic, Case Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Isaacs, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:12 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06190249 · Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable MelanomaJames Isaacs, MD · withdrawn · Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IIID Melanoma · principal investigator
- N/ANCT05079113 · Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma SettingCase Comprehensive Cancer Center · completed · Stage III Melanoma, Stage IV Cutaneous Melanoma · principal investigator
- Ph1NCT04323202 · Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&NCase Comprehensive Cancer Center · completed · Basal Cell Carcinoma of the Head and Neck · principal investigator
- Ph2NCT04187833 · Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness GenesCase Comprehensive Cancer Center · completed · Metastatic or Unresectable Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.